Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

25.93 +0.51 (+2.01%)
Streaming Delayed Price Updated: 2:55 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings ↗
Enovis develops medical devices for orthopedic care and rehabilitation, serving healthcare professionals and institutions worldwide. 
Via The Motley Fool
News headline image
Why Enovis (ENOV) Stock Is Trading Up Today
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 12.6% in the morning session after the company reported mixed fourth-quarter results but issued a strong earnings forecast for... 
Via StockStory
Topics Government World Trade
Enovis Corp (NYSE:ENOV) Reports Q4 Earnings Beat, Provides Strong 2026 EPS Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Update: Enovis Announces Fourth Quarter and Full Year 2025 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis (NYSE:ENOV) Misses Q4 CY2025 Sales Expectations
Medical technology company Enovis Corporation (NYSE:ENOV) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 2.6% year on year to $575.8 million. The company’s full-year revenue... 
Via StockStory
News headline image
Enovis Announces Fourth Quarter and Full Year 2025 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis (ENOV) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting results tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
1 Volatile Stock with Promising Prospects and 2 We Ignore
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
3 Volatile Stocks We’re Skeptical Of
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
News headline image
Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Enovis Corporation
Via GlobeNewswire
News headline image
3 Value Stocks We Keep Off Our Radar
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful... 
Via StockStory
News headline image
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
From Enovis Corporation
Via GlobeNewswire
News headline image
3 Out-of-Favor Stocks We Keep Off Our Radar
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
News headline image
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis Appoints Oliver Engert as Chief Administrative Officer
From Enovis Corporation
Via GlobeNewswire
News headline image
3 Unprofitable Stocks That Concern Us
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
Why Enovis (ENOV) Stock Is Trading Up Today
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 6.8% in the afternoon session after Freedom Capital Markets initiated coverage on the company with a "Buy" rating and set a... 
Via StockStory
Topics Artificial Intelligence Economy Supply Chain
News headline image
1 Volatile Stock for Long-Term Investors and 2 We Turn Down
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced... 
Via StockStory
News headline image
An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares ↗
This orthopedic device company attracted new insider buying after a tough year for shares, according to recent regulatory filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Small-Cap Stocks We Find Risky
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Topics Retirement
News headline image
Enovis, AMN Healthcare Services, Astrana Health, U.S. Physical Therapy, and AdaptHealth Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
3 Reasons to Avoid ENOV and 1 Stock to Buy Instead
Over the last six months, Enovis’s shares have sunk to $30.86, producing a disappointing 14.8% loss - a stark contrast to the S&P 500’s 16.3% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks
News headline image
The 5 Most Interesting Analyst Questions From Enovis’s Q3 Earnings Call
Enovis’ third quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, but the market reacted negatively to the report. Management highlighted strong organic growth across the... 
Via StockStory
Topics Earnings World Trade
News headline image
Q3 Earnings Outperformers: Enovis (NYSE:ENOV) And The Rest Of The Medical Devices & Supplies - Specialty Stocks
Looking back on medical devices & supplies - specialty stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
News headline image
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
News headline image
ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the... 
Via StockStory
Topics World Trade
News headline image
Enovis’s (NYSE:ENOV) Q3 Sales Top Estimates
Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the... 
Via StockStory
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.